Disease Info Card

Cholangitis, Sclerosing

Information about Cholangitis, Sclerosing: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Cholangitis, Sclerosing

Most recent studies have shown that Cholangitis, Sclerosing shares some biological mechanisms with autoimmune-diseases, autoimmune-reaction, biliary-cirrhosis, cholangiocarcinoma, cholangitis, cholestasis, colitis, fibrosis, hepatitis, hepatitis-autoimmune, inflammatory-bowel-diseases, intestinal-diseases, liver-cirrhosis, liver-diseases, malignant-neoplasms, neoplasms, primary-biliary-cirrhosis, stenosis, ulcer, ulcerative-colitis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Cholangitis, Sclerosing, and have been seen in publications frequently: Cell Adhesion, Cell Death, Cell Proliferation, Chemotaxis, Coagulation, Cytokine Production, Dna Repair, Excretion, Immune Response, Inflammatory Response, Intestinal Absorption, Localization, Lymphocyte Activation, Methylation, Neutrophil Activation, Pathogenesis, Phagocytosis, Regeneration, Secretion, Transport

Quite a number of genes have been found to play important roles in Cholangitis, Sclerosing, such as ABCB4, ACAD8, ALB, ALPP, ASRGL1, ATRNL1, CCL27, CD4, CFTR, DLAT, G4, GGT1, HLA-DRB4, IL10, LTA, NAT10, NOD2, SLC17A5, SLPI, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.